Completed Access to Information Requests

Follow:

  • RSS
  • Cite
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 103 record(s)

Req # A-2019-001941

Letters, notices, and email correspondence issued to Cannabis Act licence holders regarding non-compliance with the promotion prohibitions under the Cannabis Act between January 1, 2019 and February 1, 2020.

Organization: Health Canada

30 page(s)
March 2023

Req # A-2021-001315

Summary basis of decision and Instruction For Use (IFU) for Mirasol Pathogen Reduction Technology System model No. 106324.

Organization: Health Canada

302 page(s)
March 2023

Req # A-2022-001068

All internal or external evaluations about the effectiveness, efficiency, and equity of work performed by teleworkers and hybrid workers from the period of March 1, 2020 to November 1, 2022. Any manuals, guidelines, written policies, procedures and practices that your organization has developed for tele, hybrid, and on-site work for public servants since 2020. All documents that show the number of employees by their work status in March 2020, November 2021 and November 2022.

Organization: Health Canada

72 page(s)
March 2023

Req # A-2022-001307

Seizure data, sourced from Seizure and Disposition reports, on illicit opioids broken down by number of seizures, volume, year, and province. Volumes of illicit fentanyl and derivatives seized broken down by province and year. Any data relating to seizures of pharmaceutical opioids vs illicit opioids. Time Period: 2012-2022.

Organization: Health Canada

20978 page(s)
March 2023

Req # A-2022-001382

All documents listing the modalities of the Public Service Occupational Health Program (PSOHP) regarding correctional officers from the Correctional Service of Canada. The documents detailing the services offered by the Program, the conditions or eligibility criteria for certain services.

Organization: Health Canada

120 page(s)
March 2023

Req # A-2022-001444

Extract of metadata from your Access to Information and Privacy (ATIP) case management system, Ricoh ATIP Application. A machine-readable Excel file of all access to information requests received since April 1, 2016 containing the following fields: - Request number - Date request was received - Date request was due - Date request was closed, if applicable - Days taken - Days allowed - Request disposition - Date OIC complaint received, if applicable - Complaint reason.

Organization: Health Canada

151 page(s)
March 2023

Req # A-2019-001917

Adverse Drug Reaction (ADR). Report number: E2B_02737965.

Organization: Health Canada

63 page(s)
March 2023

Req # A-2022-001311

Adverse Drug Reactions (ADRs) for REXULTI, ARIPIPRAZOLE. Report numbers: E2B_05795715, E2B_05717142, E2B_05720816. ADR for REXULTI. Report number: E2B_05723433. ADRs for ABILIFY MAINTENA, ARIPIPRAZOLE. Report numbers: E2B_05724504, E2B_05717118.

Organization: Health Canada

139 page(s)
March 2023

Req # A-2022-001406

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110432-515, What We Heard Report During the 2022 Consultations on the Targeted Review of the Pest Control Products Act.

Organization: Health Canada

82 page(s)
March 2023

Req # A-2022-001434

Adverse Drug Reaction (ADR) for SOLIRIS. Report number: E2B_05935628.

Organization: Health Canada

14 page(s)
March 2023
Date modified: